Cochrane · systematic review · CD008983
Influenza vaccines in immunosuppressed adults with cancer
Bitterman, R, Eliakim‐Raz, N, Vinograd, I, et al. · Cochrane Database of Systematic Reviews · 2018 · Cochrane Library
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
4
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 2 · 50%Low 2 · 50%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Show all 2 versionsInfluenza vaccine compared to no vaccine for immunosuppressed adults with cancer
Population: immunosuppressed adults with cancer
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
All‐cause mortality, solid cancers Influenza vaccine vs no vaccine | OR 0.88 [0.78, 1] | 1 study · 1577 participants | Very low |
All‐cause mortality, solid and haematological malignancies Influenza vaccine vs no vaccine | OR 0.42 [0.24, 0.75] | 1 study · 806 participants | Very low Downgraded: imprecision |
All‐cause mortality, allogeneic BMT Influenza vaccine vs no vaccine | OR 1.25 [0.43, 3.62] | 1 study · 78 participants | Low Downgraded: imprecision |
Adjuvanted influenza vaccine compared to non‐adjuvanted influenza vaccine in immunosuppressed adults with cancer
Population: immunosuppressed adults with cancer
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
All‐cause mortality, allogeneic BMT, Adjuvanted influenza vaccine vs non‐adjuvanted influenza vaccine | RR 0.54 [0.05, 5.73] | 1 study · 73 participants | Low Downgraded: imprecision |